These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6592972)

  • 21. HLA system and penicillamine induced pemphigus in nine cases of rheumatoid arthritis.
    Bauer-Vinassac D; Menkes CJ; Muller JY; Escande JP
    Scand J Rheumatol; 1992; 21(1):17-9. PubMed ID: 1570481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [HLA system and complications of the treatment of rheumatoid polyarthritis with D-penicillamine].
    Bardin T; Dryll A; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):27-9. PubMed ID: 3486448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal polymyositis in D-penicillamine-treated rheumatoid arthritis.
    Doyle DR; McCurley TL; Sergent JS
    Ann Intern Med; 1983 Mar; 98(3):327-30. PubMed ID: 6830075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eosinophilia in rheumatoid patients treated with D-penicillamine.
    Edelman J; Maguire KF; Owen ET
    J Rheumatol; 1984 Oct; 11(5):624-5. PubMed ID: 6512792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [D-penicillamine and dermatopolymyositis. Value of the study of anti-JO 1 antibodies].
    Oberlin F; Koeger AC; Meyer O; Rosey T; Camus JP
    Presse Med; 1986 May; 15(19):887. PubMed ID: 2940560
    [No Abstract]   [Full Text] [Related]  

  • 26. Cutaneous problems with drug therapy in rheumatoid arthritis.
    Wilson CL; Bradlow A; Wojnarowska F
    Int J Dermatol; 1991 Feb; 30(2):148-9. PubMed ID: 2001908
    [No Abstract]   [Full Text] [Related]  

  • 27. D-penicillamine-induced polymyositis in patients with rheumatoid arthritis.
    Takahashi K; Ogita T; Okudaira H; Yoshinoya S; Yoshizawa H; Miyamoto T
    Arthritis Rheum; 1986 Apr; 29(4):560-4. PubMed ID: 3707633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.
    Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP; Rasker JJ; de Rooij DJ
    J Rheumatol; 1983 Dec; 10(6):948-53. PubMed ID: 6420562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
    Dequeker J; Van Wanghe P; Verdickt W
    J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
    N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eosinophilia in D-penicillamine therapy.
    Smith DH; Scott DL; Zaphiropoulos GC
    Ann Rheum Dis; 1983 Aug; 42(4):408-10. PubMed ID: 6136256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis.
    Perrier P; Raffoux C; Thomas P; Tamisier JN; Busson M; Gaucher A; Streiff F
    Ann Rheum Dis; 1985 Sep; 44(9):621-4. PubMed ID: 3876081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3.
    Emery P; Panayi GS; Huston G; Welsh KI; Mitchell SC; Shah RR; Idle JR; Smith RL; Waring RH
    J Rheumatol; 1984 Oct; 11(5):626-32. PubMed ID: 6334741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is myositis in chronic polyarthritis using d-penicillamine drug-induced?].
    Schlumpf U; Bussmann HU; Jerusalem F
    Schweiz Med Wochenschr; 1981 Jan; 111(1):29-35. PubMed ID: 6782670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histocompatibility antigens in adult obliterative bronchiolitis with or without rheumatoid arthritis.
    Sweatman MC; Markwick JR; Charles PJ; Jones SE; Prior JM; Maini RN; Turner-Warwick ME
    Dis Markers; 1986 Jun; 4(1-2):19-26. PubMed ID: 3133152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
    Pachoula-Papasteriades C; Boki K; Varla-Leftherioti M; Kappos-Rigatou I; Fostiropoulos G; Economidou J
    Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Myasthenia induced by D-penicillamine. Apropos of 2 case reports].
    Huaux JP; Delreux V
    Acta Neurol Belg; 1986; 86(5):297-303. PubMed ID: 3492852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rheumatoid arthritis: relationship with HLA-D.
    Stastny P
    Am J Med; 1983 Dec; 75(6A):9-15. PubMed ID: 6362407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancytopenia related eosinophilia in rheumatoid arthritis.
    Jaffe IA
    J Rheumatol; 1996 Feb; 23(2):406. PubMed ID: 8882061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.